Here are more detailed reasons why Dr. Yo does not
Post# of 145787
![](/assets/46931549/no_avatar_available_thumb.jpg)
Quote:
It is not going to play a role in long haulers. Neither is leronlimab or lenzilumab. 1. approval 2. cost. A lot more research needs to be done before experimental drugs can be considered for long haulers. Maybe for next pandemic (hopefully we don't see another pandemic)
Link
I disagree in that the playing field could change and these drugs may become subsidized and the best solution. No one knows how this plays out.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)